Psychological aspects in patients with advanced cancer receiving lifelong systemic treatment: protocol for a scoping review by Linda Kwakkenbos, Winette T A van der Graaf, Evie E M Kolsteren, Esther Deuning-Smit, Judith B Prins, Carla M L van Herpen, Sophie Lebel, Belinda Thewes, José A E Custers

Get full text

Real-world data on tolerability and clinical response of cemiplimab in patients with advanced cutaneous squamous cell carcinoma: A retrospective, multicentre cohort study from the... by Maartje W. Rohaan, Marleen L. Duizer, Lot A. Devriese, Aafke Meerveld-Eggink, Willem F. Brandts, Johannes V. van Thienen, Sofie Wilgenhof, Carla M.L. van Herpen, John B.A.G. Haanen

Get full text

RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer by Erik J. vanHelden, Lindsay Angus, C. Willemien Menke‐van der Houven van Oordt, Daniëlle A. M. Heideman, Eline Boon, Suzanne C. vanEs, Sandra A. Radema, Carla M. L. vanHerpen, Derk Jan A. deGroot, Elisabeth G. E. deVries, Maurice P. H. M. Jansen, Stefan Sleijfer, Henk M. W. Verheul

Get full text